Gilead Sciences Inc.
02/06/2024 | Press release | Archived content
Fourth Quarter 2023 Prepared Remarks
Sharing and Personal Tools
Please select the service you want to use:
Smartlinks | Gilead Sciences Inc. | News | Health | Biotechnology | HIV/AIDS | Biotechnology | Science | Biotechnology | Research | HIV/AIDS | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Conference Calls and Webcasts | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | Borsa Italiana | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Santiago Stock Exchange | Bolsa Mexicana de Valores (BMV) | Buenos Aires Stock Exchange (BCBA) | Lima Stock Exchange (BVL) | Moscow Exchange (MOEX) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Bolsa Electrónica de Chile | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Aquis Exchange | SIGMA X MTF | EuroTLX | Bolsa Institucional de Valores (BIVA) | Aquis Exchange Europe | Equiduct | Hannover Stock Exchange | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact